BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 8622633)

  • 1. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
    Ling YH; el-Naggar AK; Priebe W; Perez-Soler R
    Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
    Vikhanskaya F; Erba E; D'Incalci M; Broggini M
    Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells.
    Poon RY; Chau MS; Yamashita K; Hunter T
    Cancer Res; 1997 Nov; 57(22):5168-78. PubMed ID: 9371520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phorbol ester TPA rapidly prevents activation of p34cdc2 histone H1 kinase and concomitantly the transition from G2 phase to mitosis in synchronized HeLa cells.
    Barth H; Kinzel V
    Exp Cell Res; 1994 Jun; 212(2):383-8. PubMed ID: 8187833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
    Park M; Chae HD; Yun J; Jung M; Kim YS; Kim SH; Han MH; Shin DY
    Cancer Res; 2000 Feb; 60(3):542-5. PubMed ID: 10676633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase.
    Kruyt FA; Dijkmans LM; Arwert F; Joenje H
    Cancer Res; 1997 Jun; 57(11):2244-51. PubMed ID: 9187128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1.
    Nomura N; Nomura M; Newcomb EW; Zagzag D
    Biochem Pharmacol; 2007 May; 73(10):1528-36. PubMed ID: 17324379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of cisplatin on cell cycle regulators].
    Nishio K; Saijo N
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):289-94. PubMed ID: 8109984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells.
    Clemens DL; Calisto LE; Sorrell MF; Tuma DJ
    Hepatology; 2003 Aug; 38(2):385-93. PubMed ID: 12883482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B.
    Tsao YP; D'Arpa P; Liu LF
    Cancer Res; 1992 Apr; 52(7):1823-9. PubMed ID: 1312900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
    Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53.
    Minemoto Y; Gannon J; Masutani M; Nakagama H; Sasagawa T; Inoue M; Masamune Y; Yamashita K
    Exp Cell Res; 2001 Jan; 262(1):37-48. PubMed ID: 11120603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase.
    Braunagel SC; Parr R; Belyavskyi M; Summers MD
    Virology; 1998 Apr; 244(1):195-211. PubMed ID: 9581791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines.
    Wang W; Heideman L; Chung CS; Pelling JC; Koehler KJ; Birt DF
    Mol Carcinog; 2000 Jun; 28(2):102-10. PubMed ID: 10900467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide.
    Lock RB
    Cancer Res; 1992 Apr; 52(7):1817-22. PubMed ID: 1551112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells.
    Barascu A; Besson P; Le Floch O; Bougnoux P; Jourdan ML
    Int J Biochem Cell Biol; 2006 Feb; 38(2):196-208. PubMed ID: 16194618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
    Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
    Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor rapidly impairs activation of p34cdc2 protein kinase in HeLa cells at the G2-M boundary.
    Barth H; Kinzel V
    J Cell Physiol; 1995 Jan; 162(1):44-51. PubMed ID: 7814450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth condition-induced precocious activation of p34cdc2 kinase inhibits the expression of developmental competence.
    Jantzen H; Schulze I
    Dev Biol; 1994 Nov; 166(1):311-22. PubMed ID: 7958455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.